Schizophrenia, neuroleptic medication and mortality

British Journal of Psychiatry

Volumn 188, Issue FEB., 2006, Pages 122-127

  Joukamaa, Matti ^a,d   Heliövaara, Markku ^b   Knekt, Paul ^b   Aromaa, Arpo ^b   Raitasalo, Raimo ^c   Lehtinen, Ville ^b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c SOCIAL INSURANCE INSTITUTION   (Finland)

^d UNIVERSITY OF TAMPERE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CHLORPROTHIXENE; HALOPERIDOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEVOMEPROMAZINE; NEUROLEPTIC AGENT; PERPHENAZINE; THIORIDAZINE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; DOSE TIME EFFECT RELATION; DRUG FATALITY; FEMALE; FOLLOW UP; GENDER; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; RESPIRATORY TRACT DISEASE; RISK FACTOR; SCHIZOPHRENIA; SUICIDAL BEHAVIOR;

ADULT; AGE DISTRIBUTION; AGED; ANTIPSYCHOTIC AGENTS; BLOOD PRESSURE; CHOLESTEROL, HDL; EXERCISE; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; POLYPHARMACY; POPULATION SURVEILLANCE; PREVALENCE; RISK FACTORS; SCHIZOPHRENIA; SEX DISTRIBUTION; SMOKING;

EID: 31644445836     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.188.2.122     Document Type: Article

References (27)

1. Aromaa, A., Heliövaara, M., Impivaara, O., et al (1989) Aims, methods and study population. Part I. In The Execution of the Mini-Finland Health Survey (eds A. Aromaa, M. Heliövaara, O. Impivaara, et al). Publication no. ML:88. Helsinki: Social Insurance Institution.
2. Bralet, M. C., Yon, V., Loas, G., et al (2000) Causes de la mortalité chez les schizophrènes: étude prospective sur 8 ans d'une cohorte de 150 schizophrènes chroniques. Encéphale, 26, 32-41.
3. Brown, S. (1997) Excess mortality of schizophrenia. A meta-analysis. British Journal of Psychiatry, 171, 502-508.
4. Brown, S., Inskip, H. & Barraclough, B. (2000) Causes of the excess mortality of schizophrenia. British Journal of Psychiatry, 177, 212-217.
5. Cox, D. R. (1972) Regression models and life-tables. Journal of the Royal Statistical Society B, 34, 187-220.
6. Goldberg, D. P. (1972) The Detection of Psychiatric Illness by Questionnaire. Maudsley Monograph 21. London: Oxford University Press.
7. Harris, E. C. & Barraclough, B. (1998) Excess mortality of mental disorder. British Journal of Psychiatry, 173, 11-53.
8. Heilä, H. & Lönnqvist, J. (2003) The clinical epidemiology of suicide in schizophrenia. In The Epidemiology of Schizophrenia (eds R. Murray, P. Jones, E. Susser, et al), pp. 288-316. Cambridge: Cambridge University Press.
9. Joseph, K. S., Blais, L., Ernst, P., et al (1996) Increased morbidity and mortality related to asthma among asthmatic patients who use major tranquillisers. BMJ, 31, 79-82.
10. Joukamaa, M., Heliövaara, M., Knekt, P., et al (2001) Mental disorders and cause-specific mortality. British Journal of Psychiatry, 179, 498-502.
11. Lehtinen, V., Joukamaa, M., Jyrkinen, E., et al (1990a) Prevalence of mental disorders among adults in Finland. Basic results from the Mini-Finland Health Survey. Acta Psychiatrica Scandinavica, 81, 418-425.
12. Lehtinen, V., Joukamaa, M., Jyrkinen, E., et al (1990b) Need for mental health services of the adult population in Finland: results from the Mini-Finland Health Survey. Acta Psychiatrica Scandinavica, 81, 426-431.
13. Mäkelä, M., Heliövaara, M., Sievers, K., et al (1993) Musculoskeletal disorders as determinants of disability in Finns aged 30 years or more. Journal of Clinical Epidemiology, 46, 549-559.
14. Montout, C., Casadebaig, F., Lagnaoui, R., et al (2002) Neuroleptics and mortality in schizophrenia: prospective analysis of deaths in a French cohort of schizophrenic patients. Schizophrenia Research, 57, 147-156.
15. Mortensen, P. B. (2003) Mortality and physical illness in schizophrenia. In The Epidemiology of Schizophrenia (eds R. Murray, P. Jones, E. Susser, et al), pp. 275-287. Cambridge: Cambridge University Press.
16. Osby, U., Correia, N., Brandt, L., et al (2000) Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophrenia Research, 45, 21-28.
17. Ray, W. A. & Meador, K. G. (2002) Antipsychotics and sudden death: is thioridazine the only bad actor? British Journal of Psychiatry, 180, 483-484.
18. Ray, W. A., Meredith, S., Thapa, P. B., et al (2001) Antipsychotics and the risk of sudden cardiac death. Archives of General Psychiatry, 58, 1161-1167.
19. SAS Institute (1997) SAS/STAT Software: Changes and Enhancements through Release 6.12. Cary, NC: SAS Institute.
20. Thomassen, R., Vandenbroucke, J. P. & Rosendaal, F. R. (2001) Antipsychotic medication and venous thrombosis. British Journal of Psychiatry, 179, 63-66.
21. Vaisanen, E. (1975) Psychiatric disorders in Finland. Acta Psychiatrica Scandinavica Supplementum, 263, 22-33.
22. Waddington, J. L., Youssef, H. A. & Kinsella, A. (1998) Mortality in schizophrenia. Antipsychotic polypharmacy and absence of adjunctive anticholinergics over the course of a 10-year prospective study. British Journal of Psychiatry, 173, 325-329.
23. Wing, J. K., Cooper, J. E. & Sartorius, N. (1974) The Measurement and Classification of Psychiatric Symptoms. London: Cambridge University Press.
24. Wing, J. K., Mann, S. A., Leff, J. P., et al (1978) The concept of a case in psychiatric population surveys. Psychological Medicine, 8, 203-217.
25. Wirshing, D. A., Pierre, J. M., Erhart, S. M., et al (2003) Understanding the new and evolving profile of adverse drug effects in schizophrenia. Psychiatric Clinics of North America, 26, 165-190.
26. Witchel, H. J., Hancox, J. C. & Nutt, D. J. (2003) Psychotropic drugs, cardiac arrhythmia, and sudden death. Journal of Clinical Psychopharmacology, 23, 58-77.
27. World Health Organization (1974) Eighth Revision of the International Classification of Diseases and Related Health Problems (ICD-8). Geneva: WHO.